Literature DB >> 22975801

Late recurrence after resection of mass-forming intrahepatic cholangiocarcinoma: report of a case.

Naoko Iwahashi Kondo1, Ken Shirabe, Yohei Mano, Akinobu Taketomi, Tomoharu Yoshizumi, Toru Ikegami, Toshiro Masuda, Hiroto Kayashima, Naotaka Hashimoto, Kazutoyo Morita, Mizue Matsuo, Yoshihiko Maehara.   

Abstract

The outcome after surgical resection for intrahepatic cholangiocarcinoma has not been satisfactorily evaluated due to its malignant behavior. Surgical resection, however, has the potential to improve the prognosis and may allow surgeons to experience rare cases with long survival. This report presents the case of a patient who developed recurrence 9 years after resection of intrahepatic cholangiocarcinoma. A 76-year-old female was diagnosed to have intrahepatic cholangiocarcinoma and underwent an extended right posterior subsegmentectomy. The gross appearance showed a mass-forming type tumor. The histopathological examination revealed well to moderately differentiated adenocarcinoma associated with portal vein invasion. Subcutaneous metastasis in the head as the first sign of relapse was diagnosed 9 years after hepatectomy. The histopathological findings of the subcutaneous tumor were similar to those of the intrahepatic cholangiocarcinoma, thus suggesting metastasis from intrahepatic cholangiocarcinoma. Positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose was useful for detecting multiple metastases. Long-term follow-up for more than 5 years is recommended because the present case shows that late recurrence of intrahepatic cholangiocarcinoma occurs even 5 years after resection.

Entities:  

Mesh:

Year:  2012        PMID: 22975801     DOI: 10.1007/s00595-012-0332-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  25 in total

1.  Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival.

Authors:  Giorgio Ercolani; Gaetano Vetrone; Gian Luca Grazi; Osamu Aramaki; Matteo Cescon; Matteo Ravaioli; Carla Serra; Giovanni Brandi; Antonio Daniele Pinna
Journal:  Ann Surg       Date:  2010-07       Impact factor: 12.969

2.  Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Authors:  Kazuhisa Uchiyama; Masakazu Yamamoto; Hiroki Yamaue; Shun-ichi Ariizumi; Taku Aoki; Norihiro Kokudo; Tomoki Ebata; Masato Nagino; Masayuki Ohtsuka; Masaru Miyazaki; Eiichi Tanaka; Satoshi Kondo; Takahiro Uenishi; Shoji Kubo; Hiroshi Yoshida; Michiaki Unno; Satoru Imura; Mitsuo Shimada; Masaki Ueno; Tadahiro Takada
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-05       Impact factor: 7.027

3.  The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.

Authors:  Sae-Byeol Choi; Kyung-Sik Kim; Jin-Young Choi; Seung-Woo Park; Jin-Sub Choi; Woo-Jung Lee; Jae-Bock Chung
Journal:  Ann Surg Oncol       Date:  2009-07-22       Impact factor: 5.344

4.  Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.

Authors:  Jong Doo Lee; Woo Ick Yang; Young Nyun Park; Kyung Sik Kim; Jin Sub Choi; Mijin Yun; Dooheun Ko; Tae-Sung Kim; Arthur E H Cho; Hye Mi Kim; Kwang-Hyub Han; Seung-Soon Im; Yong-Ho Ahn; Chang Woon Choi; Jeon Han Park
Journal:  J Nucl Med       Date:  2005-10       Impact factor: 10.057

5.  Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.

Authors:  Kazuhiro Hirohashi; Takahiro Uenishi; Shoji Kubo; Takatsugu Yamamoto; Hiromu Tanaka; Taichi Shuto; Hiroaki Kinoshita
Journal:  Hepatogastroenterology       Date:  2002 Mar-Apr

6.  Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit.

Authors:  Akshat Saxena; Terence C Chua; Anik Sarkar; Francis Chu; David L Morris
Journal:  J Gastrointest Surg       Date:  2010-05-14       Impact factor: 3.452

7.  Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period.

Authors:  Hauke Lang; Georgios C Sotiropoulos; Nils R Frühauf; Marco Dömland; Andreas Paul; Eva-Maria Kind; Massimo Malagó; Christoph E Broelsch
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

8.  Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.

Authors:  Ken Shirabe; Yohei Mano; Akinobu Taketomi; Yuji Soejima; Hideaki Uchiyama; Shinichi Aishima; Hiroto Kayashima; Mizuki Ninomiya; Yoshihiko Maehara
Journal:  Ann Surg Oncol       Date:  2010-02-05       Impact factor: 5.344

9.  Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Tommaso Campagnaro; Silvia Pachera; Alessandro Valdegamberi; Paola Nicoli; Alessandro Cappellani; Giulio Malfermoni; Calogero Iacono
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

10.  Late recurrence after surgery for cholangiocarcinoma: implications for follow-up?

Authors:  Harun Thomas; Nigel David Heaton
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2008-10
View more
  1 in total

Review 1.  Cutaneous metastasis of cholangiocarcinoma.

Authors:  Min Liu; Bai-Long Liu; Bin Liu; Liang Guo; Qiang Wang; Yan-Qiu Song; Li-Hua Dong
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.